Clinical Trial: A Phase II Clinical Study of LBL-024 Combination Therapy in Patients With Advanced Solid Tumour[Substudy 04]

U.S., Feb. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07390383) titled 'A Phase II Clinical Study of LBL-024 Combination Therapy in Patients With Advanced Solid Tumour[Substudy 04]' on Jan. 29.

Brief Summary: An Open-label, Multicenter, Phase II Clinical Study to Evaluate the Efficacy and Safety of LBL-024 in Combination With Other Drugs for the Treatment of Patients With Advanced Solid Tumour.

Study Start Date: March 25

Study Type: INTERVENTIONAL

Condition: Advanced Solid Tumour

Intervention: DRUG: LBL-024 for Injection

Intravenous infusion

DRUG: Capecitabine tablets

Oral administration

DRUG: Tislelizumab Injection

Intravenous infusion

DRUG: Oxaliplatin injection

Intravenous infusion

Recru...